| RS2105983330 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2105984736 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2105985030 |
ATIC
|
Health Risk |
Conflicting classifications of pathogenicity |
AICA-ribosiduria, AICA-ribosiduria |
| RS2105985080 |
HIBCH
|
Health Risk |
Likely pathogenic |
3-hydroxyisobutyryl-CoA hydrolase deficiency, 3-hydroxyisobutyryl-CoA hydrolase deficiency |
| RS2105986664 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2105986813 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2105987094 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2105987421 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2105987749 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2105987971 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2105988065 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2105990789 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2105992974 |
ABCA12
|
Health Risk |
Likely pathogenic |
Abnormality of the skin, Autosomal recessive congenital ichthyosis 4A |
| RS2105996078 |
ABCB11
|
Health Risk |
Likely pathogenic |
— |
| RS2105998730 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Amyotrophic lateral sclerosis |
| RS2105999102 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2105999112 |
ALS2
|
Health Risk |
Pathogenic |
— |
| RS2106001462 |
ALS2
|
Health Risk |
Likely pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2106002050 |
BMPR2
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension, Drug- or toxin-induced pulmonary arterial hypertension |
| RS2106002172 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2106003122 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary venoocclusive disease 1, Pulmonary venoocclusive disease 1 |
| RS2106003228 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2106003241 |
BMPR2
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension, Pulmonary arterial hypertension |
| RS2106003724 |
ALS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2106004648 |
ABCB11
|
Health Risk |
Likely pathogenic |
— |
| RS2106004684 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2106004956 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2106005174 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2106005949 |
ALS2
|
Health Risk |
Likely pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2106005994 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2106008336 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2106008354 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2106008473 |
BMPR2
|
Health Risk |
Pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS2106009582 |
ALS2
|
Health Risk |
Likely pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2106010718 |
WNT10A
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2106010917 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2106011673 |
WNT10A
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2106011709 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2106011732 |
WNT10A
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2106012637 |
ALS2
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 2, juvenile |
| RS2106013953 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2106014776 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106015063 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106015104 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106016170 |
WNT10A
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2106016227 |
WNT10A
|
Health Risk |
Pathogenic |
Odonto-onycho-dermal dysplasia, Tooth agenesis |
| RS2106016293 |
WNT10A
|
Health Risk |
Pathogenic |
Odonto-onycho-dermal dysplasia, Tooth agenesis |
| RS2106016375 |
WNT10A
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2106018181 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2106018205 |
WNT10A
|
Health Risk |
Pathogenic/Likely pathogenic |
Tooth agenesis, selective |
| RS2106018209 |
BMPR2
|
Health Risk |
Pathogenic |
— |
| RS2106018239 |
WNT10A
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2106018257 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2106018397 |
WNT10A
|
Health Risk |
Pathogenic/Likely pathogenic |
Tooth agenesis, selective |
| RS2106018559 |
WNT10A
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2106018668 |
WNT10A
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2106018717 |
WNT10A
|
Health Risk |
Pathogenic |
Odonto-onycho-dermal dysplasia, Tooth agenesis |
| RS2106019982 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2106020004 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2106020684 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106020733 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106020750 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106021020 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106021114 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106023727 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Amyotrophic lateral sclerosis type 2 |
| RS2106028466 |
OBSL1
|
Health Risk |
Likely pathogenic |
3M syndrome 2, 3M syndrome 2 |
| RS2106029186 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106029249 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106030892 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2106033603 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106037172 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106037184 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106038518 |
BARD1
|
Health Risk |
Pathogenic |
Malignant tumor of breast, Malignant tumor of breast |
| RS2106040403 |
SMARCAL1
|
Health Risk |
Likely pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106042103 |
BMPR2
|
Health Risk |
Likely pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2106042155 |
BMPR2
|
Health Risk |
Likely pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2106042216 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS2106042229 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension, Idiopathic and/or familial pulmonary arterial hypertension |
| RS2106047848 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2106050388 |
SMARCAL1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS2106054066 |
ABCA12
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2106055125 |
ABCB11
|
Health Risk |
Likely pathogenic |
— |
| RS2106055226 |
SMARCAL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephrotic syndrome, Schimke immuno-osseous dysplasia |
| RS2106071765 |
ALS2
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 2, juvenile |
| RS2106071898 |
LOC126806529;PAX3
|
Health Risk |
Pathogenic |
— |
| RS2106072248 |
PAX3
|
Health Risk |
Pathogenic |
— |
| RS2106073127 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106074168 |
PAX3
|
Health Risk |
Pathogenic |
— |
| RS2106074229 |
ALS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormal central motor function, Infantile-onset ascending hereditary spastic paralysis |
| RS2106074302 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2106074565 |
PAX3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 3, Waardenburg syndrome type 3 |
| RS2106074603 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS2106075317 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106076108 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Familial cancer of breast |
| RS2106076135 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Gastric cancer |
| RS2106076147 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106076340 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Familial cancer of breast |
| RS2106076377 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106076564 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106076720 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |